Login / Signup

Management of secondary aorto-enteric fistulae: a multi-centre study.

Anantha NarayananJoseph HannaAmy Okamura-KhoJoshua TesarEric T A LimSam PedenAnastasia DeanLupe TaumoepeauNedal KatibOliver LyonsManar Khashram
Published in: ANZ journal of surgery (2023)
In this study there was no difference in all-cause survival in patients who had OAR or EVAR as first line treatment for SAEF. In the acute setting, alongside broad-spectrum antimicrobial therapy, EVAR can be considered as an initial treatment for patients with SAEF, as a primary treatment or a bridge to definitive OAR.
Keyphrases
  • radiation therapy
  • squamous cell carcinoma
  • bone marrow
  • combination therapy
  • mesenchymal stem cells
  • replacement therapy
  • cell therapy
  • aortic dissection